RecruitingNCT06801392
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
The Acute Efficacy and Safety of Left Atrial Posterior Wall and Mitral Isthmus Ablation in Patients With Non-Paroxysmal Atrial Fibrillation
Sponsor
Charles University, Czech Republic
Enrollment
50 participants
Start Date
Jan 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- non-paroxysmal atrial fibrillation
- an indication for catheter ablation according current guidelines
- willingness to sign informed content.
Exclusion Criteria3
- hematological disorders that can be associated with spontaneous hemolysis
- chronic kidney disease stage 3 or worse
- previous left atrial ablation (either using pulsed-field or radiofrequency energy)
Interventions
PROCEDUREpulsed-field ablation
PVI + PW ablation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06801392
Related Trials
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT0678446626 locations
COCONUT Study Concomitant PVI and LAAC
NCT068616731 location
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT0717542837 locations
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
NCT071307731 location
LA Function After PFA in Paroxysmal AF
NCT074390161 location